|
A-dmDT390-bisFv(UCHT1) |
|---|---|
| Trade Name | Resimmune |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-09 00:00:00 |
| Sponsor | Angimmune, LLC;American Red Cross Holland Laboratory, 15601 Crabbs Branch Way;Rockville, Maryland, 20855 |
Related Access Program
